ENVISIA THERAPEUTICS ANNOUNCES COMPANY PRESIDENT, DR. BEN YERXA, WILL PRESENT AT THE 35th J.P. MORGAN HEALTHCARE CONFERENCE

ENVISIA THERAPEUTICS ANNOUNCES COMPANY PRESIDENT, DR. BEN YERXA, WILL PRESENT AT THE 35th J.P. MORGAN HEALTHCARE CONFERENCE

RESEARCH TRIANGLE PARK, NC January 4, 2017 – Envisia Therapeutics today announced that Company President, Dr. Benjamin Yerxa, has been invited to present at the 35th Annual J.P. Morgan Healthcare Conference taking place January 9 -13th, 2017 in San Francisco, CA. The J.P. Morgan Healthcare Conference continues to be one of the life science industry’s largest conferences of the year, bringing thousands of investors and executives from around the world to exchange the latest innovations in the industry. Read more here.

Copyright 2013 Envisia Therapeutics